Recently, researchers have focused on PLAU and its interactome in malignant tumors due to its role in proliferation, metastasis, and angiogenesis, and its aberrant expression in various cancers, suggesting its use as a diagnostic biomarker and therapeutic target [26–28]. This evidence concerns the gene PLAU and cancer.